IMPACT OF FUNDED RESEARCH: Individual Grants
We have awarded $8.1 million since December 2004 to investigators working on promising CLL projects. There have been several rounds of funding. Click on the pictures and project titles below to learn more about recent grant recipients and their projects. Click here to see a list of previously funded projects.
|
Exploiting HIF inhibition as a new therapeutic strategy for CLL
Rosa Bernardi, Ph.D.
San Raffaele Scientific Institute
Ospedale San Raffaele, Milan, Italy |
|
|
Microvesicles in CLL: Predictors of Disease Progression and Therapeutic Outcome?
Asish Ghosh, BS, MS, Ph.D.
Mayo Clinic
|
|
|
B-cell receptor and CXCR4 cross-talk in chronic lymphocytic lymphoma; relevance for new
signaling inhibitors
Graham Packham, Ph.D.
University of Southampton, United Kingdom |
|
|
Understanding and overcoming mutant p53 mediated resistance in CLL
Alfonso Quintás-Cardama, M.D.
University of Texas MD Anderson Cancer Center |
|
|
